These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
517 related items for PubMed ID: 15698406
1. Outcome after orthotopic liver transplantation in five HIV-infected patients with virus hepatitis-induced cirrhosis. Radecke K, Frühauf NR, Miller M, Ross B, Köditz R, Malagó M, Broelsch CE, Gerken G, Treichel U. Liver Int; 2005 Feb; 25(1):101-8. PubMed ID: 15698406 [Abstract] [Full Text] [Related]
2. Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease. Neff GW, Bonham A, Tzakis AG, Ragni M, Jayaweera D, Schiff ER, Shakil O, Fung JJ. Liver Transpl; 2003 Mar; 9(3):239-47. PubMed ID: 12619020 [Abstract] [Full Text] [Related]
3. Outcomes of liver transplantation in HIV-infected individuals: the impact of HCV and HBV infection. Norris S, Taylor C, Muiesan P, Portmann BC, Knisely AS, Bowles M, Rela M, Heaton N, O'Grady JG. Liver Transpl; 2004 Oct; 10(10):1271-8. PubMed ID: 15376307 [Abstract] [Full Text] [Related]
4. Long-term follow-up of liver transplanted HIV/hepatitis B virus coinfected patients: perfect control of hepatitis B virus replication and absence of mitochondrial toxicity. Tateo M, Roque-Afonso AM, Antonini TM, Medja F, Lombes A, Jardel C, Teicher E, Sebagh M, Roche B, Castaing D, Samuel D, Duclos-Vallee JC. AIDS; 2009 Jun 01; 23(9):1069-76. PubMed ID: 19417577 [Abstract] [Full Text] [Related]
5. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center. Testillano M, Fernandez JR, Suarez MJ, Gastaca M, Bustamante J, Pijoan JI, Montejo M, Valdivieso A, Ruiz P, Gonzalez J, Ortiz de Urbina J. Transplant Proc; 2009 Apr 01; 41(3):1041-3. PubMed ID: 19376421 [Abstract] [Full Text] [Related]
6. Liver transplantation and hepatitis C virus. Results in a Spanish center since 1989. Loinaz C, Lumbreras C, Moreno E, Colina F, Fuertes A, Gómez R, Jiménez C, González-Pinto I, García I, Rojas J, Bellorín C. Hepatogastroenterology; 2001 Apr 01; 48(41):1435-42. PubMed ID: 11677981 [Abstract] [Full Text] [Related]
13. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study. Murillas J, Rimola A, Laguno M, de Lazzari E, Rascón J, Agüero F, Blanco JL, Moitinho E, Moreno A, Miró JM, ESLD-HIV Working Group Investigators. Liver Transpl; 2009 Sep 01; 15(9):1133-41. PubMed ID: 19718643 [Abstract] [Full Text] [Related]
15. Evidence of serious graft damage induced by de novo hepatitis B virus infection after liver transplantation. Segovia R, Sánchez-Fueyo A, Rimola A, Grande L, Bruguera M, Costa J, Soguero C, Uriz J. Liver Transpl; 2001 Feb 01; 7(2):106-12. PubMed ID: 11172393 [Abstract] [Full Text] [Related]
17. [Prevention of viral recurrence following liver transplantation for post-hepatitis B and B-delta cirrhosis]. Mentha G, Giostra E, Perrin L, Widmann JJ, Stelling MJ, Easton J, Morel P, Huber O, Le Coultre C, Bühler L. Schweiz Med Wochenschr; 1994 Apr 16; 124(15):637-41. PubMed ID: 8191267 [Abstract] [Full Text] [Related]